The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lyons Gary A since 2015.
This trader's CIK number is 1123343.
At the time of last reporting, Lyons Gary A was the Director of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | BBI | 0 | $0 | 0 | $0 | 8,333 | $0 |
| 2016 | BBI | 7,078 | $31,086 | 7,078 | $16,251 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | TVTX | 0 | $0 | 40,000 | $590,040 | 40,000 | $419,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NBIX | 0 | $0 | 15,000 | $2,289,090 | 16,435 | $718,350 |
| 2024 | NBIX | 0 | $0 | 25,000 | $3,575,356 | 27,100 | $1,068,999 |
| 2023 | NBIX | 0 | $0 | 25,000 | $3,009,710 | 15,000 | $194,700 |
| 2022 | NBIX | 0 | $0 | 35,000 | $3,665,510 | 30,000 | $290,550 |
| 2021 | NBIX | 0 | $0 | 17,000 | $1,768,081 | 0 | $0 |
| 2019 | NBIX | 0 | $0 | 20,000 | $1,971,795 | 0 | $0 |
| 2018 | NBIX | 0 | $0 | 40,000 | $4,043,484 | 15,000 | $105,750 |
| 2017 | NBIX | 0 | $0 | 10,000 | $729,180 | 15,000 | $51,000 |
| 2016 | NBIX | 0 | $0 | 0 | $0 | 15,000 | $46,050 |
| 2015 | NBIX | 0 | $0 | 45,000 | $2,068,350 | 15,000 | $71,400 |
1. Fresh Tracks Therapeutics, Inc. (BBI)
2. Travere Therapeutics, Inc. (TVTX)
3. Neurocrine Biosciences Inc (NBIX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-31 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-07-31 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-06-30 | BBI | Option Ex | 691 | .00 | 0 |
| 2020-04-30 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-03-31 | BBI | Option Ex | 691 | .00 | 0 |
| 2020-02-29 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-05-31 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-02-14 | BBI | Option Ex | 3,491 | .00 | 0 |
| 2016-12-05 | VICL | Sale | 7,078 | 2.30 | 16,251 |
| 2016-06-03 | VICL | Buy | 7,078 | 4.39 | 31,086 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-04 | TVTX | Option Ex | 40,000 | 10.48 | 419,200 |
| 2024-10-04 | TVTX | Sale | 40,000 | 14.75 | 590,040 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-03 | NBIX | Sale | 15,000 | 152.61 | 2,289,090 |
| 2025-12-03 | NBIX | Option Ex | 15,000 | 47.89 | 718,350 |
| 2025-05-22 | NBIX | Option Ex | 1,435 | .00 | 0 |
| 2024-08-13 | NBIX | Sale | 11,570 | 150.43 | 1,740,451 |
| 2024-08-13 | NBIX | Option Ex | 11,570 | 42.76 | 494,733 |
| 2024-07-16 | NBIX | Sale | 930 | 150.03 | 139,530 |
| 2024-07-16 | NBIX | Option Ex | 930 | 42.76 | 39,766 |
| 2024-05-17 | NBIX | Option Ex | 2,100 | .00 | 0 |
| 2024-05-14 | NBIX | Sale | 12,500 | 135.63 | 1,695,375 |
| 2024-05-14 | NBIX | Option Ex | 12,500 | 42.76 | 534,500 |
| 2023-12-22 | NBIX | Sale | 10,000 | 130.04 | 1,300,440 |
| 2023-12-01 | NBIX | Sale | 5,000 | 116.77 | 583,835 |
| 2023-12-01 | NBIX | Option Ex | 5,000 | 12.98 | 64,900 |
| 2023-09-12 | NBIX | Option Ex | 5,000 | 12.98 | 64,900 |
| 2023-09-12 | NBIX | Sale | 5,000 | 115.02 | 575,120 |
| 2023-09-01 | NBIX | Option Ex | 5,000 | 12.98 | 64,900 |
| 2023-09-01 | NBIX | Sale | 5,000 | 110.06 | 550,315 |
| 2022-10-31 | NBIX | Option Ex | 15,000 | 12.71 | 190,650 |
| 2022-10-31 | NBIX | Sale | 15,000 | 114.76 | 1,721,400 |
| 2022-10-04 | NBIX | Sale | 5,000 | 110.54 | 552,710 |
| 2022-04-25 | NBIX | Option Ex | 15,000 | 6.66 | 99,900 |
| 2022-04-25 | NBIX | Sale | 15,000 | 92.76 | 1,391,400 |
| 2021-10-07 | NBIX | Sale | 5,000 | 105.06 | 525,295 |
| 2021-06-10 | NBIX | Sale | 10,000 | 100.27 | 1,002,740 |
| 2021-01-25 | NBIX | Sale | 1,600 | 120.03 | 192,046 |
| 2021-01-26 | NBIX | Sale | 400 | 120.00 | 48,000 |
| 2019-11-08 | NBIX | Sale | 5,000 | 110.00 | 550,000 |
| 2019-11-01 | NBIX | Sale | 5,000 | 100.22 | 501,105 |
| 2019-07-30 | NBIX | Sale | 10,000 | 92.07 | 920,690 |
| 2018-11-02 | NBIX | Sale | 15,000 | 114.41 | 1,716,210 |
| 2018-06-13 | NBIX | Sale | 15,000 | 99.24 | 1,488,555 |
| 2018-04-03 | NBIX | Option Ex | 15,000 | 7.05 | 105,750 |
| 2018-02-15 | NBIX | Sale | 5,000 | 84.67 | 423,340 |
| 2018-02-05 | NBIX | Sale | 5,000 | 83.08 | 415,379 |
| 2017-12-01 | NBIX | Sale | 10,000 | 72.92 | 729,180 |
| 2017-02-14 | NBIX | Option Ex | 15,000 | 3.40 | 51,000 |
| 2016-05-06 | NBIX | Option Ex | 15,000 | 3.07 | 46,050 |
| 2015-09-18 | NBIX | Sale | 15,000 | 54.83 | 822,450 |
| 2015-03-24 | NBIX | Sale | 30,000 | 41.53 | 1,245,900 |
| 2015-02-10 | NBIX | Option Ex | 7,500 | 4.76 | 35,700 |
| 2015-01-20 | NBIX | Option Ex | 7,500 | 4.76 | 35,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lyons Gary A (Director of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.